Related Experiment Video
Updated: May 24, 2026

Utilizing an Orally Dissolving Strip for Pharmacological and Toxicological Studies: A Simple and Humane Alternative to Oral Gavage for Animals
Published on: March 23, 2016
Orally disintegrating olanzapine review: effectiveness, patient preference, adherence, and other properties
William Montgomery1, Tamas Treuer, Jamie Karagianis
1Global Health Outcomes, Eli Lilly and Company, Sydney, Australia.
Abstract:
Orally disintegrating olanzapine (ODO) is a rapid-dissolving formulation of olanzapine which disintegrates in saliva almost immediately, developed as a convenient and adherence-enhancing alternative to the standard olanzapine-coated tablet (SOT). Clinical studies, which form the basis of this review, have shown ODO and SOT to have similar efficacy and tolerability profiles. However, ODO appears to have a number of advantages over SOT in terms of adherence, patient preference, and reduction in nursing burden. Overall, the existing clinical data suggests that compared to SOT, ODO is not only well-suited for difficult-to-treat, agitated, and/or nonadherent patients but, due to its potential ability to improve adherence and greater patient preference, may also be an appropriate formulation for the majority of patients for which olanzapine is the antipsychotic of choice.
Related Concept Videos
Oral Drug Delivery Systems: Introduction
Drug Delivery Systems: Different Types
Oral Drug Delivery Systems: Continuous-Release Systems
Psychosis: Goals of Pharmacotherapy
Antipsychotic Drugs: Typical and Atypical Agents
Factors Affecting Dissolution: Particle Size and Effective Surface Area
